Skrivanek, Z., Berry, S., Berry, D., Chien, J., Geiger, M. J., Anderson, J. H., & Gaydos, B. (2012). Application of Adaptive Design Methodology in Development of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Statistical Design and Simulations. Diabetes Technology Society.
Citação norma ChicagoSkrivanek, Zachary, Scott Berry, Don Berry, Jenny Chien, Mary Jane Geiger, James H. Anderson, e Brenda Gaydos. Application of Adaptive Design Methodology in Development of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Statistical Design and Simulations. Diabetes Technology Society, 2012.
Citação norma MLASkrivanek, Zachary, et al. Application of Adaptive Design Methodology in Development of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Statistical Design and Simulations. Diabetes Technology Society, 2012.